Bodycote plc
BYPLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -5.7% | 7.9% | 20.8% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 14.4% | 13.5% | 13.1% | 38.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | -$0 | $0 |
| Operating Expenses | -$0 | -$0 | -$0 | $0 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 15.3% | 14.9% | 13.7% | 13.6% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 2.6% | 10.7% | 9.9% | 9.7% |
| EPS | 0.11 | 0.45 | 0.39 | 0.31 |
| % Growth | -75.6% | 15.4% | 25.8% | – |
| EPS Diluted | 0.11 | 0.45 | 0.39 | 0.31 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 16% | 24.8% | 24.7% | 26.8% |